The TAKE method based on CRISPR/Cas9 technology generated a G to A change resulting in a glycine to serine substitution at amino acid 25 (p.G25S). (J:305716)
查看原文 参与反馈
The TAKE method based on CRISPR/Cas9 technology generated a G to A change resulting in a glycine to serine substitution at amino acid 25 (p.G25S). (J:305716)